Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
Scilex Holding Company announced that its subsidiaries ACEA Therapeutics and ACEA Pharma entered into a definitive agreement to sell 100% of ACEA Pharma's equity interests to Phoenix Asia Holdings Limited. The transaction involves Phoenix issuing 100 million new shares valued at $10 each to ACEA Therapeutics, representing a $1 billion valuation. Up…